Codexis (CDXS) Retained Earnings (2010 - 2026)
Codexis (CDXS) recorded quarterly Retained Earnings of -$11000.0 in Q1 2026, up 100.0% quarter-over-quarter from -$606.8 million in Q4 2025, and down 178.57% on a YoY basis from $14000.0 in Q1 2025.
Codexis (CDXS) Retained Earnings (2010 - 2026) Analysis & Trends
Codexis' Retained Earnings history runs 17 years deep, the most recent figure standing at -$11000.0 for Q1 2026.
- In Q1 2026, Retained Earnings fell 178.57% year-over-year to -$11000.0; the TTM figure through Mar 2026 stood at -$11000.0 (down 178.57% YoY), while the FY2025 annual figure was -$606.8 million, down 7.81% from the prior year.
- Retained Earnings was -$11000.0 for Q1 2026 at Codexis, up from -$606.8 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $14000.0 in Q1 2025 to a low of -$616.4 million in Q3 2025.
- Historically, Retained Earnings has averaged -$399.6 million across 5 years, with a median of -$449.7 million in 2023.
- The sharpest annual moves came in 2025 and 2026: Retained Earnings soared 100.0% in 2025, then plunged 178.57% in 2026.
- A 5-year view of Retained Earnings shows it stood at -$421.3 million in 2022, then retreated by 16.39% to -$490.3 million in 2023, then slipped by 14.78% to -$562.8 million in 2024, then decreased by 7.81% to -$606.8 million in 2025, then surged by 100.0% to -$11000.0 in 2026.
- The last three Retained Earnings figures came in at -$11000.0 (Q1 2026), -$606.8 million (Q4 2025), and -$616.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -838.07 Mn |
| 10 | Codexis | 236.00 Mn | 170.86 Mn | 13.18 Mn | -11,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11,000.00 |
| Dec 31, 2025 | -606.78 Mn |
| Sep 30, 2025 | -616.38 Mn |
| Jun 30, 2025 | -3,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Dec 31, 2024 | -562.81 Mn |
| Sep 30, 2024 | -552.43 Mn |
| Jun 30, 2024 | -531.79 Mn |
| Mar 31, 2024 | -509.04 Mn |
| Sep 30, 2023 | -490.34 Mn |
| Jun 30, 2023 | -455.43 Mn |
| Mar 31, 2023 | -443.91 Mn |
| Dec 31, 2022 | -421.29 Mn |
| Sep 30, 2022 | -408.69 Mn |
| Jun 30, 2022 | -398.69 Mn |
| Mar 31, 2022 | -396.05 Mn |
| Dec 31, 2021 | -387.70 Mn |
| Sep 30, 2021 | -377.51 Mn |
| Jun 30, 2021 | -379.75 Mn |
| Mar 31, 2021 | -375.49 Mn |